IDEAYA Biosciences Inc (IDYA)
43.09
+0.91
(+2.16%)
USD |
NASDAQ |
May 06, 16:00
43.08
-0.01
(-0.02%)
After-Hours: 20:00
IDEAYA Biosciences Free Cash Flow (Quarterly): -24.59M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -24.59M |
| September 30, 2023 | -30.78M |
| June 30, 2023 | -34.34M |
| March 31, 2023 | -27.88M |
| December 31, 2022 | -23.37M |
| September 30, 2022 | -25.27M |
| June 30, 2022 | -21.93M |
| March 31, 2022 | -20.05M |
| December 31, 2021 | -17.26M |
| September 30, 2021 | -12.93M |
| June 30, 2021 | -13.51M |
| March 31, 2021 | -14.73M |
| Date | Value |
|---|---|
| December 31, 2020 | -11.78M |
| September 30, 2020 | 89.96M |
| June 30, 2020 | -13.68M |
| March 31, 2020 | -9.545M |
| December 31, 2019 | -8.922M |
| September 30, 2019 | -10.63M |
| June 30, 2019 | -10.72M |
| March 31, 2019 | -10.39M |
| December 31, 2018 | -7.785M |
| September 30, 2018 | -9.692M |
| June 30, 2018 | -6.108M |
| March 31, 2018 | -5.743M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-34.34M
Minimum
Jun 2023
89.96M
Maximum
Sep 2020
-12.73M
Average
-14.73M
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
| Merck & Co Inc | 2.229B |
| Pfizer Inc | 4.196B |
| Geron Corp | -62.87M |
| Verastem Inc | -29.68M |
| Karyopharm Therapeutics Inc | -18.58M |